Trial Profile
Ridaforolimus + rifampicin pharmacokinetics in male volunteers
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 12 Mar 2011
Price :
$35
*
At a glance
- Drugs Ridaforolimus (Primary) ; Ketoconazole; Rifampicin
- Indications Bacterial infections; Breast cancer; Cancer; Endometrial cancer; Neurodegenerative disorders; Non-small cell lung cancer; Prostate cancer; Sarcoma; Solid tumours
- Focus Pharmacokinetics
- 12 Mar 2011 New trial record